KT

Kiran Trimbak Naik

Active Director Director DIN 10727834
DIN 10727834 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiran Trimbak Naik

Data last updated:

Kiran Trimbak Naik is a Director at Xfusion Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10727834
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20242024Active

Board colleagues of Kiran Trimbak Naik

NameDINCompanyDesignation
Shrihari Anil Nahulikar10727833Xfusion Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Xfusion Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kiran Trimbak Naik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Trimbak Naik

Kiran Trimbak Naik currently holds 1 directorship: Xfusion Pharmaceutical Private Limited (Director, since 01 Aug 2024).

Kiran Trimbak Naik was first appointed on 01 Aug 2024 as Director at Xfusion Pharmaceutical Private Limited.

The current boards of Kiran Trimbak Naik's companies include Shrihari Anil Nahulikar (Xfusion Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available